MTBP (Mdm2 Binding Protein) is a critical regulatory protein that has garnered attention for its role in cell cycle progression and its involvement in tumorigenesis. Functionally, MTBP interacts with Mdm2, a key regulator of the p53 tumor suppressor, suggesting a complex role in the p53 signaling pathway. This interaction is crucial for the maintenance of genomic stability, as it modulates the activity of Mdm2 and, consequently, the p53 response to DNA damage and stress. The significance of MTBP extends beyond its interaction with Mdm2, implicating it in the regulation of cell proliferation, migration, and invasion. Through its influence on these fundamental cellular processes, MTBP plays a pivotal role in maintaining cellular homeostasis and responding to oncogenic stress. The intricate balance of MTBP expression and activity is essential for the proper function of cell cycle checkpoints and may influence the cellular response to interventions.
The activation of MTBP involves a network of signaling pathways that modulate its expression levels, stability, and interaction with partner proteins such as Mdm2. Post-translational modifications (PTMs) of MTBP, including phosphorylation and ubiquitination, have been proposed as mechanisms that regulate its function and stability, thereby influencing MTBP's activity and its interaction with Mdm2. The activation of MTBP can be prompted by cellular stress signals, leading to alterations in its expression or PTMs, which in turn modulate the MTBP-Mdm2-p53 axis. This modulation can affect cell cycle arrest, apoptosis, and DNA repair mechanisms, highlighting the importance of MTBP in cellular stress responses. The precise mechanisms underlying MTBP activation, its regulation by PTMs, and its interaction with cellular signaling pathways remain areas of active investigation. Understanding these processes is crucial for elucidating the role of MTBP in cancer biology and for exploring targets within the MTBP-Mdm2-p53 signaling axis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PRIMA-1MET | 5291-32-7 | sc-361295 sc-361295A | 10 mg 25 mg | $153.00 $325.00 | 5 | |
PRIMA-1 reactivates mutant p53, which may indirectly affect MTBP through altered p53-MDM2 dynamics. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Piperlongumine increases p53 levels in cancer cells, potentially affecting MTBP indirectly by influencing p53 pathway activity. | ||||||
Deoxyschizandrin | 61281-38-7 | sc-278925 | 10 mg | $80.00 | ||
Deoxyschizandrin can enhance p53 activity, potentially impacting MTBP indirectly through the p53 signaling pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, a proteasome inhibitor, can stabilize p53, potentially affecting MTBP through altered p53-MDM2 interaction dynamics. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can modulate p53 signaling, potentially influencing MTBP indirectly through its impact on the p53-MDM2 pathway. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can influence p53 activity, potentially impacting MTBP indirectly through modulation of the p53-MDM2 interaction. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can affect p53 pathway, potentially influencing MTBP indirectly through modulation of the p53-MDM2 dynamics. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin can activate p53, potentially impacting MTBP indirectly through its influence on the p53-MDM2 interaction. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil can induce p53 activity, potentially affecting MTBP indirectly via the p53-MDM2 signaling axis. | ||||||